Overall, these results indicated the timing of the host response (Time) needed to be further investigated for its importance in determining infection outcomes in terms of disease.
We now know that there is an important immunotherapy that is associated with a survival advantage, but that, as with most immunotherapies, it can take some time before the host response becomes effective.
In order to analyze, for the first time, the transcriptional host response of swine tracheal epithelial (NPTr) cells to H1N1 swine influenza virus (swH1N1) infection, S. suis serotype 2 infection and a dual infection, we carried out a comprehensive gene expression profiling using a microarray approach.
In patients who achieve a complete response during treatment, no tumor samples are available to biopsy to provide a dynamic real-time interaction between host response and tumor.
Again, we only studied one time point, precluding insight into the time course of the host response; hence, it cannot learn on the processes driving the adverse events neither.
One such effort is the planned launch this fall of nine "standards" in areas such as host response time and cleanliness.
We believe that this is the first time that variation in the host response to infection with A(H1N1 pdm09 before and after anti-influenza therapy has been studied, providing new information on the A(H1N1 pdm09 infection process.
In tandem, we investigated variation in the host response by profiling time and temperature-dependent global gene expression profiles in the main lymphopoietic tissues in frogs, the spleen by using microarrays and qRT-PCR transcriptomic strategies.
At the same time, these mechanisms greatly impair the host response towards secondary unrelated pathogens.
We have used a zebrafish yolk injection system to study bacterial proliferation and the host response in a time course experiment of S. epidermidis infection.
